To further investigate the role of KMT2D as a tumor suppressor in human HNSCC, we generated KMT2D knockout (KMT2D-KO) SCC23 HNSCC cells by CRISPR-Cas9 mediated gene editing. This evidence concerns the gene KMT2D and neoplasm.